EA8143

Please Note: This trial is no longer enrolling new participants

A Phase 3 Randomized Study Comparing Perioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)

Perioperative therapy in renal cancer in the era of immune checkpoint inhibitor therapy
Kuusk T;Abu-Ghanem Y;Mumtaz F;Powles T;Bex A;
Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
Marconi L;Sun M;Beisland C;Klatte T;Ljungberg B;Stewart GD;Dabestani S;Choueiri TK;Bex A;
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
Allaf ME;Kim SE;Master V;McDermott DF;Harshman LC;Cole SM;Drake CG;Signoretti S;Akgul M;Baniak N;Li-Ning E;Palmer MB;Emamekhoo H;Adra N;Kaimakliotis H;Ged Y;Pierorazio PM;Abel EJ;Bilen MA;Ogan K;Moon HH;Ramaswamy KA;Singer EA;Mayer TM;Lohrey J;Margulis V;Gills J;Delacroix SE;Waples MJ;James AC;Wang P;Choueiri T;Michaelson MD;Kapoor A;Heng DY;Shuch B;Leibovich BC;Lara PN;Manola J;Maskens D;Battle D;Uzzo R;Bratslavsky G;Haas NB;Carducci MA;